Lung Nodule Follow-up Guide

Our biggest update yet: Lung-RADS v2022 + ‘S’ modifier, live scoring card, and expert self-assessment packs—smarter lung nodule management on your device.

Download includes a free trial; continued use requires a 6‑ or 12‑month auto‑renewing subscription.

Lung Nodule Follow-up Guide is a clinical decision-support guide that streamlines the evaluation and management of lung nodules discovered incidentally or through screening. Built on the Fleischner Society Guidelines 2017 and ACR Lung-RADS v2022, including the latest "S" modifier for clinically significant incidental findings, the app provides clear, step-by-step guidance at the point of care. Whether you're in radiology, pulmonology, or primary care, Lung Nodule Follow-up Guide helps you apply standardized recommendations with clarity and consistency.

Key Features (unlocked after the free trial with an active subscription)

Fleischner Society Guideliens 2017 Integration • Structured recommendations for both solid and sub-solid (non-solid and part-solid) nodules—based on nodule size, nodule attenuation, whether solitary or multiple, and patient-specific risk factors.

ACR Lung‑RADS v2022 Integration • Full, in‑app access to every Lung‑RADS category (0–4X) plus the “S” modifier, with concise management instructions drawn directly from the guidelines.

Dynamic Lung‑RADS Card • A single, color‑coded card that updates your Lung‑RADS score in real time as you enter screening round, nodule morphology, size, and growth—making classification fast.

S Modifier Integration • Toggle clinically significant findings across organ systems (e.g., coronary calcium, thyroid nodule, liver lesion) and instantly receive tailored, ACR‑based follow‑up recommendations sourced from the ACR Incidental Findings White Papers.

Common Issues Insights • Provides literature-backed guidance on frequently encountered challenges in managing lung nodules—whether incidental or identified through lung cancer screening. Covers key topics such as accurate nodule measurement, interpretation of modifiers, and stepwise management strategies, helping clinicians apply guidelines with precision and consistency.

Self-Assessment Mode • Expert-curated self-assessment question packs.

Brock (Full Model) Calculator • Calculate a CT-detected nodule’s 2–4 year malignancy risk.

Enhanced Readability • Dark‑mode support, dynamic text sizing, and a distraction‑free interface optimized for hectic reading environments.

Offline Access • All guideline logic run on‑device—no login or server needed.

Medical Disclaimer: This app is for informational purposes only and is not a substitute for professional medical advice. In addition to using this app, always consult a qualified healthcare provider for diagnosis and treatment decisions.

SUBSCRIPTION OPTIONS ¹

• 6‑Month subscription (free trial available) | Price displayed in‑app; may vary by region • 12‑Month subscription (free trial available) | Price displayed in‑app; may vary by region

We strive to incorporate any updates to ACR Lung‑RADS or S Modifier guidance within 30 days of publication and plan to add new self‑assessment question packs every six months.

Future feature additions and update frequency may change without notice.

¹ Payment & Renewal – Payment is charged to your Apple ID at confirmation. Subscriptions renew automatically unless auto-renew is turned off at least 24 hours before the end of the current period. Manage or cancel anytime in Settings ▸ Apple ID ▸ Subscriptions.

Note: If you switch plans or re-subscribe during the free trial, the remaining trial time is lost and you will be charged immediately.

Privacy Policy: https://radiologiq.squarespace.com/privacy Terms of Use (EULA): https://www.apple.com/legal/internet-services/itunes/dev/stdeula/